Loss of RET Promotes Mesenchymal Identity in Neuroblastoma Cells

Aberrant activation of anaplastic lymphoma kinase (ALK) drives neuroblastoma (NB). Previous work identified the RET receptor tyrosine kinase (RTK) as a downstream target of ALK activity in NB models. We show here that ALK activation in response to ALKAL2 ligand results in the rapid phosphorylation o...

Full description

Bibliographic Details
Main Authors: Joachim T. Siaw, Jonatan L. Gabre, Ezgi Uçkun, Marc Vigny, Wancun Zhang, Jimmy Van den Eynden, Bengt Hallberg, Ruth H. Palmer, Jikui Guan
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/8/1909
_version_ 1797537588473495552
author Joachim T. Siaw
Jonatan L. Gabre
Ezgi Uçkun
Marc Vigny
Wancun Zhang
Jimmy Van den Eynden
Bengt Hallberg
Ruth H. Palmer
Jikui Guan
author_facet Joachim T. Siaw
Jonatan L. Gabre
Ezgi Uçkun
Marc Vigny
Wancun Zhang
Jimmy Van den Eynden
Bengt Hallberg
Ruth H. Palmer
Jikui Guan
author_sort Joachim T. Siaw
collection DOAJ
description Aberrant activation of anaplastic lymphoma kinase (ALK) drives neuroblastoma (NB). Previous work identified the RET receptor tyrosine kinase (RTK) as a downstream target of ALK activity in NB models. We show here that ALK activation in response to ALKAL2 ligand results in the rapid phosphorylation of RET in NB cells, providing additional insight into the contribution of RET to the ALK-driven gene signature in NB. To further address the role of RET in NB, <i>RET</i> knockout (KO) SK-N-AS cells were generated by CRISPR/Cas9 genome engineering. Gene expression analysis of <i>RET</i> KO NB cells identified a reprogramming of NB cells to a mesenchymal (MES) phenotype that was characterized by increased migration and upregulation of the AXL and MNNG HOS transforming gene (MET) RTKs, as well as integrins and extracellular matrix components. Strikingly, the upregulation of AXL in the absence of RET reflects the development timeline observed in the neural crest as progenitor cells undergo differentiation during embryonic development. Together, these findings suggest that a MES phenotype is promoted in mesenchymal NB cells in the absence of RET, reflective of a less differentiated developmental status.
first_indexed 2024-03-10T12:17:18Z
format Article
id doaj.art-61061a11b5bb4c9eb230c207089ae54f
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T12:17:18Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-61061a11b5bb4c9eb230c207089ae54f2023-11-21T15:44:13ZengMDPI AGCancers2072-66942021-04-01138190910.3390/cancers13081909Loss of RET Promotes Mesenchymal Identity in Neuroblastoma CellsJoachim T. Siaw0Jonatan L. Gabre1Ezgi Uçkun2Marc Vigny3Wancun Zhang4Jimmy Van den Eynden5Bengt Hallberg6Ruth H. Palmer7Jikui Guan8Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, SE-40530 Gothenburg, SwedenDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, SE-40530 Gothenburg, SwedenDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, SE-40530 Gothenburg, SwedenUniversité Pierre et Marie Curie, UPMC, INSERM UMRS-839, 75005 Paris, FranceDepartment of Pediatric Oncology Surgery, Children’s Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, ChinaAnatomy and Embryology Unit, Department of Human Structure and Repair, Ghent University, 9000 Ghent, BelgiumDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, SE-40530 Gothenburg, SwedenDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, SE-40530 Gothenburg, SwedenDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, SE-40530 Gothenburg, SwedenAberrant activation of anaplastic lymphoma kinase (ALK) drives neuroblastoma (NB). Previous work identified the RET receptor tyrosine kinase (RTK) as a downstream target of ALK activity in NB models. We show here that ALK activation in response to ALKAL2 ligand results in the rapid phosphorylation of RET in NB cells, providing additional insight into the contribution of RET to the ALK-driven gene signature in NB. To further address the role of RET in NB, <i>RET</i> knockout (KO) SK-N-AS cells were generated by CRISPR/Cas9 genome engineering. Gene expression analysis of <i>RET</i> KO NB cells identified a reprogramming of NB cells to a mesenchymal (MES) phenotype that was characterized by increased migration and upregulation of the AXL and MNNG HOS transforming gene (MET) RTKs, as well as integrins and extracellular matrix components. Strikingly, the upregulation of AXL in the absence of RET reflects the development timeline observed in the neural crest as progenitor cells undergo differentiation during embryonic development. Together, these findings suggest that a MES phenotype is promoted in mesenchymal NB cells in the absence of RET, reflective of a less differentiated developmental status.https://www.mdpi.com/2072-6694/13/8/1909ALKALKAL2EMTneural differentiationadrenergicretinoic acid
spellingShingle Joachim T. Siaw
Jonatan L. Gabre
Ezgi Uçkun
Marc Vigny
Wancun Zhang
Jimmy Van den Eynden
Bengt Hallberg
Ruth H. Palmer
Jikui Guan
Loss of RET Promotes Mesenchymal Identity in Neuroblastoma Cells
Cancers
ALK
ALKAL2
EMT
neural differentiation
adrenergic
retinoic acid
title Loss of RET Promotes Mesenchymal Identity in Neuroblastoma Cells
title_full Loss of RET Promotes Mesenchymal Identity in Neuroblastoma Cells
title_fullStr Loss of RET Promotes Mesenchymal Identity in Neuroblastoma Cells
title_full_unstemmed Loss of RET Promotes Mesenchymal Identity in Neuroblastoma Cells
title_short Loss of RET Promotes Mesenchymal Identity in Neuroblastoma Cells
title_sort loss of ret promotes mesenchymal identity in neuroblastoma cells
topic ALK
ALKAL2
EMT
neural differentiation
adrenergic
retinoic acid
url https://www.mdpi.com/2072-6694/13/8/1909
work_keys_str_mv AT joachimtsiaw lossofretpromotesmesenchymalidentityinneuroblastomacells
AT jonatanlgabre lossofretpromotesmesenchymalidentityinneuroblastomacells
AT ezgiuckun lossofretpromotesmesenchymalidentityinneuroblastomacells
AT marcvigny lossofretpromotesmesenchymalidentityinneuroblastomacells
AT wancunzhang lossofretpromotesmesenchymalidentityinneuroblastomacells
AT jimmyvandeneynden lossofretpromotesmesenchymalidentityinneuroblastomacells
AT bengthallberg lossofretpromotesmesenchymalidentityinneuroblastomacells
AT ruthhpalmer lossofretpromotesmesenchymalidentityinneuroblastomacells
AT jikuiguan lossofretpromotesmesenchymalidentityinneuroblastomacells